SCHEMBL17017653

SCHEMBL17017653

c1ccc(-c2ccc(-c3nc(-c4ccc(-n5c6ccccc6c6c7ccn(-c8ccccc8)c7ccc65)cc4)nc4ccccc34)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
ATM Q13315 3/20 0.46
MEN1 O00255 3/20 0.46
ABCG2 Q9UNQ0 1/20 0.36
MAPT P10636 3/20 0.35
NPSR1 Q6W5P4 2/20 0.35
PTK2B Q14289 1/20 0.35
KDM4E B2RXH2 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
PDE5A O76074 3/20 0.34
ADORA2A P29274 1/20 0.34
NUDT1 P36639 1/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
WHR1 P49842 1/20 0.34
ACP1 P24666 2/20 0.33
HSP90AA1 P07900 1/20 0.33
HTR7 P34969 1/20 0.32
LMNA P02545 1/20 0.32
GBA1 P04062 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17017637 0.99 KMT2A (0.47) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017664 0.95 KMT2A (0.41) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017661 0.94 KMT2A (0.40) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017663 0.94 KMT2A (0.43) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017651 0.93 KMT2A (0.40) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017650 0.93 KMT2A (0.41) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017655 0.92 ATM (0.39) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017681 0.92 MEN1 (0.42) KMT2AATMMEN1ABCG2MAPT
SCHEMBL15596825 0.92 ATM (0.43) KMT2AATMMEN1ABCG2MAPT
SCHEMBL17017657 0.91 KMT2A (0.39) KMT2AATMMEN1ABCG2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9905777-B2 Compound and organic electroluminescence device comprising same DOOSAN CORPORATION (KR) 2018-02-27 US disclosed
US-9905777-B2 Compound and organic electroluminescence device comprising same DOOSAN CORPORATION (KR) 2018-02-27 US disclosed
US-20150236271-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed
US-20150236271-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME DOOSAN CORPORATION (KR) 2015-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150236271-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING SAME OR10J3, VDAC1, VDAC2 KMT2A 1420/4885ATM 3382/4885MEN1 1762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.